225 related articles for article (PubMed ID: 2168703)
1. Biochemical and pharmacological evaluation of the novel antidepressant and serotonin uptake inhibitor 2-(3,4-Dichlorobenzyl)-2-dimethylamino-1-propanol hydrochloride.
Gouret CJ; Porsolt R; Wettstein JG; Puech A; Soulard C; Pascaud X; Junien JL
Arzneimittelforschung; 1990 Jun; 40(6):633-40. PubMed ID: 2168703
[TBL] [Abstract][Full Text] [Related]
2. In vivo characterization of T-794, a novel reversible inhibitor of monoamine oxidase-A, as an antidepressant with a wide safety margin.
Kato M; Katayama T; Iwata H; Yamamura M; Matsuoka Y; Narita H
J Pharmacol Exp Ther; 1998 Mar; 284(3):983-90. PubMed ID: 9495858
[TBL] [Abstract][Full Text] [Related]
3. Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin.
Koe BK; Weissman A; Welch WM; Browne RG
J Pharmacol Exp Ther; 1983 Sep; 226(3):686-700. PubMed ID: 6310078
[TBL] [Abstract][Full Text] [Related]
4. Preclinical evaluation of McN-5707 as a potential antidepressant.
Shank RP; Gardocki JF; Schneider CR; Vaught JL; Setler PE; Maryanoff BE; McComsey DF
J Pharmacol Exp Ther; 1987 Jul; 242(1):74-84. PubMed ID: 3039115
[TBL] [Abstract][Full Text] [Related]
5. Potential antidepressant activity and enhancement of serotonin uptake of a new dibenzothiadiazepine derivative.
Borsini F; Volterra G; Lecci A; Evangelista S; Mancinelli A; Cutrufo C; Parlani M; Mennini T; Barone D; Meli A
Arzneimittelforschung; 1991 Jun; 41(6):573-80. PubMed ID: 1718290
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of lortalamine, a new potent non-tricyclic antidepressant.
Depin JC; Betbeder-Matibet A; Bonhomme Y; Muller AJ; Berthelon JJ
Arzneimittelforschung; 1985; 35(11):1655-62. PubMed ID: 4091869
[TBL] [Abstract][Full Text] [Related]
7. Behavioral effects and general pharmacology of 4-(5-chloro-benzofuranyl-2)-1-methylpiperidine HC1, an antidepressant inhibiting both monoamine oxidase A and 5-hydroxytryptamine uptake.
Ortmann R; Radeke E; Buech O; Sigg K; Rogg H; Glatt A; Truog A; Jaekel J; Everitt BJ; Delini-Stula A
Arzneimittelforschung; 1986 Dec; 36(12):1727-32. PubMed ID: 3566833
[TBL] [Abstract][Full Text] [Related]
8. Prolonged treatment with the specific 5-HT-uptake inhibitor citalopram: effect on dopaminergic and serotonergic functions.
Arnt J; Hyttel J; Overø KF
Pol J Pharmacol Pharm; 1984; 36(2-3):221-30. PubMed ID: 6591152
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic profile of fezolamine fumarate: a nontricyclic antidepressant in animal models.
Baizman ER; Ezrin AM; Ferrari RA; Luttinger D
J Pharmacol Exp Ther; 1987 Oct; 243(1):40-54. PubMed ID: 3668867
[TBL] [Abstract][Full Text] [Related]
10. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
Jolas T; Haj-Dahmane S; Kidd EJ; Langlois X; Lanfumey L; Fattaccini CM; Vantalon V; Laporte AM; Adrien J; Gozlan H
J Pharmacol Exp Ther; 1994 Mar; 268(3):1432-43. PubMed ID: 8138956
[TBL] [Abstract][Full Text] [Related]
11. On the mechanism of antidepressant-like action of berberine chloride.
Kulkarni SK; Dhir A
Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): in vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activity.
Dawson LA; Hughes ZA; Starr KR; Storey JD; Bettelini L; Bacchi F; Arban R; Poffe A; Melotto S; Hagan JJ; Price GW
Neuropharmacology; 2006 Jun; 50(8):975-83. PubMed ID: 16581092
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and pharmacological activity of befuraline (N-benzo[b]furan-2-ylcarbonyl-N'-benzylpiperazine), a new antidepressant compound.
Boksay IJ; Popendiker K; Weber RO; Söder A
Arzneimittelforschung; 1979; 29(2):193-204. PubMed ID: 582130
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological evaluation of 2-(4-methylaminobutoxy)diphenylmethane hydrochloride (MCI-2016), a new psychotropic drug with antidepressant activity.
Tobe A; Yoshida Y; Ikoma H; Tonomura S; Kikumoto R
Arzneimittelforschung; 1981; 31(8):1278-85. PubMed ID: 7197535
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological profile of AD-5423, a novel antipsychotic with both potent dopamine-D2 and serotonin-S2 antagonist properties.
Oka M; Noda Y; Ochi Y; Furukawa K; Une T; Kurumiya S; Hino K; Karasawa T
J Pharmacol Exp Ther; 1993 Jan; 264(1):158-65. PubMed ID: 8093723
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological profile of binedaline, a new antidepressant drug.
Morin D; Zini R; Urien S; Tillement JP
J Pharmacol Exp Ther; 1989 Apr; 249(1):288-96. PubMed ID: 2540319
[TBL] [Abstract][Full Text] [Related]
17. Minaprine, a new drug with antidepressant properties.
Bizière K; Worms P; Kan JP; Mandel P; Garattini S; Roncucci R
Drugs Exp Clin Res; 1985; 11(12):831-40. PubMed ID: 3836113
[TBL] [Abstract][Full Text] [Related]
18. Regionally specific neural adaptation of beta adrenergic and 5-hydroxytryptamine2 receptors after antidepressant administration in the forced swim test and after chronic antidepressant drug treatment.
Paul IA; Duncan GE; Powell KR; Mueller RA; Hong JS; Breese GR
J Pharmacol Exp Ther; 1988 Sep; 246(3):956-62. PubMed ID: 2843636
[TBL] [Abstract][Full Text] [Related]
19. Some central effects of tiflucarbine, a new potential antidepressant drug.
Maj J; Rogóz Z; Sowińska H; Zalewski Z
Pol J Pharmacol Pharm; 1987; 39(1):63-74. PubMed ID: 2823240
[TBL] [Abstract][Full Text] [Related]
20. N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-nitrophenyl) cyclohexanecarboxamide: a novel pre- and postsynaptic 5-hydroxytryptamine(1A) receptor antagonist active on the lower urinary tract.
Leonardi A; Guarneri L; Poggesi E; Angelico P; Velasco C; Cilia A; Testa R
J Pharmacol Exp Ther; 2001 Dec; 299(3):1027-37. PubMed ID: 11714892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]